USPTO serial 79233960
REVLANTE
Reviewed by CopyMark Law Group
Reg. 6191892Status 404
- Filing date
- Status date
- Registration date
- Nov 10, 2020
- Examiner
- AIKENS, RONALD E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with REVLANTE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 11, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 21, 2023 | FINP | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 28, 2022 | FISN | FINAL DECISION PROCESSED AND SENT TO IB | — |
| Nov 10, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 25, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 5, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 5, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 5, 2020 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 21, 2020 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Jul 21, 2020 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Jul 16, 2020 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Jul 3, 2020 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| May 27, 2020 | CRTP | REG. CANCELLED - RESTORED TO PENDENCY | — |
| May 27, 2020 | APET | ASSIGNED TO PETITION STAFF | — |
| May 26, 2020 | RCII | REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED | — |
| Mar 1, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 16, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 16, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 3, 2019 | GPAR | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | — |
| Dec 20, 2018 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Dec 4, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 2, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 18, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 5, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 5, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 29, 2018 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 5, 2018 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jul 4, 2018 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 19, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 19, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 16, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 12, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 11, 2018 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jun 7, 2018 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |